Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Depreciation and Depletion (2021 - 2025)

Biote (BTMD) has 5 years of Depreciation and Depletion data on record, last reported at $200000.0 in Q3 2025.

  • For Q3 2025, Depreciation and Depletion rose 900.0% year-over-year to $200000.0; the TTM value through Sep 2025 reached $1.3 million, up 452.17%, while the annual FY2024 figure was $800000.0, 0.0% changed from the prior year.
  • Depreciation and Depletion reached $200000.0 in Q3 2025 per BTMD's latest filing, roughly flat from $200000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $670000.0 in Q4 2024 and bottomed at $10000.0 in Q2 2024.
  • Average Depreciation and Depletion over 5 years is $223555.6, with a median of $200000.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: tumbled 96.67% in 2024, then skyrocketed 1900.0% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $180000.0 in 2021, then skyrocketed by 66.67% to $300000.0 in 2022, then tumbled by 66.67% to $100000.0 in 2023, then skyrocketed by 570.0% to $670000.0 in 2024, then plummeted by 70.15% to $200000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $200000.0 in Q3 2025, $200000.0 in Q2 2025, and $200000.0 in Q1 2025.